LAB REPORT
|
|
Investigation
|
Result
|
Unit
|
Normal Range
|
|
|
CBC
|
|
Total Count WBC
Blood/ Automated |
5000
|
Cells/cmm
|
4000 - 11000
|
|
Hemoglobin
Blood/ Automated |
13.9
|
g/dL
|
13.0 - 17.0
|
|
PCV
Blood/ Automated |
41.7
|
%
|
40 - 50
|
|
Platelets
Blood/ Automated |
367
|
thou cells/ ul
|
150 - 400
|
|
RBC Count
Blood/ Automated |
4.63
|
million/ul
|
4.5 - 5.5
|
|
MCV
Blood/ Automated |
99.5
|
fl
|
80 - 100
|
|
MCH
Blood/ Automated |
28.1
|
pg
|
27 - 32
|
|
MCHC
Blood/ Automated |
28.3
|
gm %
|
32 - 36
|
|
Neutrophils
Blood/ Automated |
49
|
%
|
40 - 65
|
|
Lymphocytes
Blood/ Automated |
45
|
%
|
30 - 50
|
|
Monocytes
Blood/ Automated |
03
|
%
|
02 - 04
|
|
Eosinophils
Blood/ Automated |
03
|
%
|
02 - 08
|
|
Basophils
Blood/ Automated |
00
|
%
|
0 - 1
|
|
|
FREE T4,TSH
|
|
Free T4
CLIA |
1.38
|
ng/dL
|
0.7 - 1.48
|
|
TSH
Method: CLIA |
1.21
|
mIU/L
|
Adults : 0.35 - 5.1 Newborn - 4 Days : 1.0 - 38.9 Child - 14 Years : 1.0 - 9.1
Pregnancy Ranges::::,
Ist Tri :0.1 - 2.5,
IInd Tri :0.2 - 3.0,
IIIrd Tri:0.3 - 3.0,
|
|
|
Liver Function Test (LFT)
|
|
Total Bilirubin
|
0.63
|
mg/dL
|
|
|
Direct Bilirubin
Method: DSA / SERUM |
0.24
|
mg/dl
|
Up to 0.4
|
|
Indirect Bilirubin
Method : Calculation / SERUM |
0.39
|
|
|
|
SGPT (ALT)
Method: UV without pyridoxal phosphate / SERUM |
14
|
IU/L
|
Adult
Male :<45
Female:<34
|
|
SGOT (AST)
Method: UV without pyridoxal phosphate / SERUM |
17
|
U/L
|
Adult
Male :<35
Female:<31
|
|
Gamma Glutamyl transferase (GGT)
( Method: IFCC - Enzymatic Colorimetric / SERUM |
7.15
|
U/L
|
Up to 55 U/L
|
|
Alkaline Phosphotase
Method : P-NPP/IFCC / SERUM |
44
|
IU/L
|
Children : 180 - 341
(Age and gender dependent)
16 - 18 years 52 - 171
> 18 years 30 - 120
|
|
Total Protein
Method: Biuret / SERUM |
5.45
|
g/dl
|
Adult : 6.4 - 8.3
|
|
Albumin (serum)
Method: Bromocresol Green/ SERUM |
4.15
|
g/dL
|
Adult - 3.5 - 5.2
|
|
Globulin
Method : Calculation |
1.3
|
g/dl
|
2.6 - 4.1
|
|
A\G RATIO
Method : Calculation |
3.2
|
g/dl
|
1.5 - 3.3 g/dl
|
|
|
Lipid Profile
|
|
Total Cholesterol
Method: Enzymatic/CHOD/PAP / SERUM |
208
|
mg/dl
|
Desirable : <200
Borderline high : 200 - 239
High : >239
|
|
TGL Triglyceride
Method: Glycerol-3-phosphate oxidase-PAP/ SERUM |
85
|
mg/dL
|
Less than 200 : desirable
200 - 400 :Normal Risk
More than 400 :High Risk
|
|
HDL High Density Lipoprotein
Method : Direct / SERUM |
52
|
mg/dL
|
Low :< 40
High :>=60
|
|
LDL Low Density Lipoprotein
Method : Homogenous Enzymatic colorimetric / Serum |
138
|
mg/dL
|
Optimal :<100
Near or above optimal : 100 - 129
Borderline high : 130 - 159
High : 160 - 189
Very high :>190
|
|
VLDL
Method : Calculation |
17.2
|
mg/dl
|
15 - 35 mg/dl
|
|
TOTAL CHO/HDL RATIO
Method : Calculation |
4.0
|
|
up to 5.0
|
|
|
Other
|
|
Fasting Plasma Glucose (FPG)
Method :GOD- POD / PLASMA |
95
|
mg/dL
|
Adult : 70 - 110
Children : 60 - 100
|
|
Post Prandial Glucose (2hPP)
Method :GOD- POD / PLASMA |
104
|
mg/dL
|
80 - 140
|
|
Glycosylated Hemoglobin (HBA1C)
HPLC |
6.70
|
%
|
Non Diabetic : Less than 5.6%
Risk of Diabetes : 5.7% - 6.4 %
Diabetes : More than 6.5%
In known Diabetics :-
Good Control : 6 - 7 %
Fair Control : 7 - 8 %
Poor Control : More than 8 %
|
|
BUN Blood Urea Nitrogen
Method : GLDH/Urease |
29
|
mg/dL
|
6 - 24
|
|
Creatinine
Method : Enzymatic / SERUM |
0.90
|
mg/dL
|
Cord : 0.6-1.2
Newborn
1-4 days : 0.3 - 1.0
Infant : 0.2 - 0.4
Child : 0.3 - 0.7
Adolescent: 0.5 - 1.0
Adult (18 - 60 years)
Male : 0.62 - 1.1
Female :0.45 - 0.75
|
|
Microalbumin Creatinine Ratio
|
264
|
mcg/mg
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
